Lupin informs about US FDA inspection

28 Sep 2024 Evaluate
Lupin has informed that the US FDA inspected Lupin’s Pithampur Unit-1 API and finished product manufacturing facility from September 16 to September 27, 2024. The inspection closed with three observations each on the API and Finished Product side. They are addressing the observations comprehensively and will respond to the US FDA within the stipulated timeframe. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2069.90 -9.60 (-0.46%)
30-Dec-2025 13:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1708.25
Dr. Reddys Lab 1260.30
Cipla 1479.95
Zydus Lifesciences 899.15
Lupin 2069.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×